{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:58:57Z","timestamp":1779879537981,"version":"3.53.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210779","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T18:25:47Z","timestamp":1547835947000},"page":"e0210779","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital"],"prefix":"10.1371","volume":"14","author":[{"given":"Jo\u00e3o Paulo Vilela","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Angelo","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Rosa Freato","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-4641","authenticated-orcid":true,"given":"Mar\u00edlia Silveira de Almeida","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Marques dos","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela Roque Siani","family":"Morelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fontoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Maria Pereira","family":"Girolineto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Palmira Miranda de Camargo","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edlio de Souza","family":"Cazarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro C\u00e9sar da Silva","family":"Maduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo R\u00e9gis Leira","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"issue":"3","key":"ref1","first-page":"533","article-title":"Opportunities and responsibilities in pharmaceutical care","volume":"47","author":"CD Hepler","year":"1990","journal-title":"Am J Hosp Pharm"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/pds.1984","article-title":"Adverse drug events in the outpatient setting: an 11-year national analysis","volume":"19","author":"FT Bourgeois","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review","volume":"63","author":"RL Howard","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsps.2011.04.004","article-title":"Study on drug related admissions in a tertiary care hospital in South India","volume":"19","author":"MS Sekhar","year":"2011","journal-title":"Saudi Pharm J"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1592\/phco.28.6.816","article-title":"The Definition of Clinical Pharmacy","volume":"28","year":"2008","journal-title":"Pharmacoterapy"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1002\/phar.1459","article-title":"Clinical Pharmacy Should Adopt a Consistent Process of Direct Patient Care","volume":"34","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"31","key":"ref7","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.2174\/1381612043382576","article-title":"The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience","volume":"10","author":"LM Strand","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"23","key":"ref8","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2146\/ajhp060674","article-title":"Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist","volume":"64","author":"BJ Kopp","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11096-014-0008-9","article-title":"Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature","volume":"36","author":"J Gallagher","year":"2014","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"e010003","DOI":"10.1136\/bmjopen-2015-010003","article-title":"Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis","volume":"6","author":"AB Mekonnen","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.amjopharm.2012.06.001","article-title":"Pharmacist- Versus Physician-Initiated Admission Medication Reconciliation: Impact on Adverse Drug Events","volume":"10","author":"KA Mergenhagen","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1345\/aph.1H495","article-title":"Neurology and Neurosurgery Clinical Pharmacy Practice: Ignorance, Phobia or Progress?","volume":"40","author":"TE Welty","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"G Zaccara","year":"2014","journal-title":"Epileptic Disord"},{"key":"ref14","article-title":"Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases","author":"MAS Ali","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40120-016-0046-4","article-title":"Medication Therapy Management Service for Patients with Parkinson\u2019s Disease: A Before-and-After Study","volume":"5","author":"AA Foppa","year":"2016","journal-title":"Neurol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12955-014-0162-8","article-title":"Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study)","volume":"12","author":"M Losada-Camacho","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"ref17","article-title":"Epidemiologia","author":"RR Luiz","year":"2006"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2710.1997.95975959.x","article-title":"A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit","volume":"22","author":"CP Alderman","year":"1997","journal-title":"J Clin Pharm Ther"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1345\/aph.1L045","article-title":"Assessment of clinical pharmacists&apos; interventions in French hospitals: results of a multicenter study","volume":"42","author":"P Bedouch","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4321\/S1886-36552009000200003","article-title":"Impact of pharmacist\u2019s interventions on cost of drug therapy in intensive care unit","volume":"7","author":"S Saokaew","year":"2009","journal-title":"Pharm Pract (Granada)"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11096-010-9367-z","article-title":"Clinical pharmacists\u2019 interventions in a German University Hospital","volume":"32","author":"C Langebrake","year":"2010","journal-title":"Pharm World Sci"},{"issue":"1","key":"ref22","first-page":"11","article-title":"Evaluation of pharmacy students\u2019 clinical interventions on a general medicine practice experience","volume":"9","author":"JD Jones","year":"2011","journal-title":"Pharmacy Practice (Granada)"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.1971.00310130105017","article-title":"Quality control and the medical record","volume":"127","author":"LL Weed","year":"1971","journal-title":"Arch Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12911-016-0341-0","article-title":"Determinants of a successful problem list to support the implementation of the problem-oriented medical record according to recent literature","volume":"16","author":"SMJ Simons","year":"2016","journal-title":"BMC Med Inform Decis Mak"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2146\/ajhp060682","article-title":"Clinical documentation for patient care: models, concepts, and liability considerations for pharmacists","volume":"64","author":"S Zierler-Brown","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"ref26","article-title":"The Clinician\u2019s Guide","author":"RJ Cipolle","year":"2004"},{"key":"ref27","article-title":"Guidelines for ATC classification and DDD assignment","year":"2013"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1041610211002511","article-title":"Cognitive impairment and vitamin B12: a review","volume":"24","author":"E Moore","year":"2012","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7861\/clinmedicine.15-2-145","article-title":"Vitamin B12 deficiency\u2014A 21st century perspective","volume":"15","author":"MJ Shipton","year":"2015","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11096-015-0224-y","article-title":"An evaluation of clinical pharmacist service on a neurology care unit","volume":"38","author":"ZM Yi","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12882-017-0596-4","article-title":"Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis","volume":"18","author":"HH Lazrak","year":"2017","journal-title":"BMC Nephrol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"SR Kahn","year":"2012","journal-title":"Chest"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2146\/ajhp060624","article-title":"Antidopaminergic therapy for managing comorbidities in patients with Parkinson&apos;s disease","volume":"65","author":"U Lertxundi","year":"2008","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.maturitas.2016.06.006","article-title":"Deprescribing in older people","volume":"91","author":"AT Page","year":"2016","journal-title":"Maturitas"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14740338.2018.1397625","article-title":"A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms","volume":"17","author":"E Reeve","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1358\/dot.2018.54.8.2856495","article-title":"Deprescribing medications in older people: a narrative review","volume":"54","author":"MS Salahudeen","year":"2018","journal-title":"Drugs Today (Barc)"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1573403X1103150514155757","article-title":"Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease","volume":"11","author":"H Agrawal","year":"2015","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/jrpp.JRPP_16_160","article-title":"Developing an Economic Case of Clinical Pharmacists\u00b4 Interventions on Venous Thromboembolism Prophylaxis Through Service Evaluation","volume":"6","author":"EH Lee","year":"2017","journal-title":"J Res Pharm Pract"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.4088\/JCP.13f08668","article-title":"Levothyroxine in psychiatry: issues related to absorption after oral dosing","volume":"74","author":"C Andrade","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"ref41","first-page":"451","article-title":"Levothyroxine absorption in health and disease, and new therapeutic perspectives","volume":"18","author":"G Ianiro","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref42","article-title":"Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study","author":"M Skelin","year":"2018","journal-title":"Endocrine"},{"key":"ref43","unstructured":"World Health Organization. A global brief hypertension, 2013. Available from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/79059\/1\/WHO_DCO_WHD_2013.2_eng.pdf?ua=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/79059\/1\/WHO_DCO_WHD_2013.2_eng.pdf?ua=1<\/ext-link>. Accessed November 15, 2017."},{"key":"ref44","unstructured":"World Health Organization. Global report on Diabetes, 2016. Available from <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/204871\/1\/9789241565257_eng.pdf?ua=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/204871\/1\/9789241565257_eng.pdf?ua=1<\/ext-link>. Accessed November 15, 2017."},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11096-017-0548-x","article-title":"Clinical impact of an interdisciplinary patient safety program for managing drug-related problems in a long-term care hospital","volume":"39","author":"O Ruiz-Millo","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11096-017-0585-5","article-title":"Drug related problems identified by clinical pharmacist at Internal Medicine Ward in Turkey","volume":"40","author":"N Abunahlah","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S1984-82502016000100016","article-title":"Medication reconciliation as a strategy for preventing medication errors","volume":"52","author":"LR Spalla","year":"2016","journal-title":"Braz J Pharm Sci"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.18549\/PharmPract.2017.02.901","article-title":"Impact of a pharmacy technician-centered medication reconciliation program on medication discrepancies and implementation of recommendations","volume":"15","author":"SK Kraus","year":"2017","journal-title":"Pharm Pract"},{"issue":"26","key":"ref49","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"NE Gilhus","year":"2016","journal-title":"N Engl J Med"},{"issue":"10076","key":"ref50","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","article-title":"Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function","volume":"389","author":"D Ontaneda","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"ref51","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1345\/aph.1L045","article-title":"Assessment of clinical pharmacists&apos; interventions in French hospitals: results of a multicenterstudy","volume":"42","author":"P Bedouch","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11096-010-9367-z","article-title":"Clinical pharmacists\u2019 interventions in a German University Hospital","volume":"32","author":"C Langebrake","year":"2010","journal-title":"Pharm World Sci"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.2146\/ajhp150368","article-title":"Cost-avoidance and qualitative analysis of clinical pharmacy interventions by psychiatric pharmacy residents at state psychiatric facilities","volume":"73","author":"KN Gardner","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/phar.1777","article-title":"Evaluation of Clinical Pharmacists\u2019 Interventions in the Czech Republic","volume":"36","author":"J Rychl\u00edckov\u00e1","year":"2016","journal-title":"Pharmacotherapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T23:06:24Z","timestamp":1606086384000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210779"}},"subtitle":[],"editor":[{"given":"John","family":"Rovers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210779","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]}}}